A detailed history of Franklin Resources Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 338,184 shares of VKTX stock, worth $23.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
338,184
Previous 340,511 0.68%
Holding current value
$23.3 Million
Previous $27.9 Million 35.79%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$47.39 - $80.2 $110,276 - $186,625
-2,327 Reduced 0.68%
338,184 $17.9 Million
Q1 2024

May 13, 2024

BUY
$17.4 - $94.5 $5.66 Million - $30.8 Million
325,453 Added 2161.33%
340,511 $27.9 Million
Q4 2023

Feb 09, 2024

SELL
$9.24 - $19.64 $301,963 - $641,835
-32,680 Reduced 68.46%
15,058 $280,000
Q3 2023

Nov 13, 2023

SELL
$10.92 - $16.0 $121,321 - $177,760
-11,110 Reduced 18.88%
47,738 $528,000
Q2 2023

Aug 11, 2023

BUY
$14.84 - $24.79 $873,304 - $1.46 Million
58,848 New
58,848 $953,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.28B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.